Effect of intravenous alizapride on spinal morphine-induced pruritus

Br J Anaesth. 2003 Aug;91(2):287-9. doi: 10.1093/bja/aeg164.

Abstract

Background: This double-blind study was undertaken to determine whether alizapride inhibits spinal morphine-induced pruritus.

Methods: Eighty-four patients undergoing Caesarean section under spinal anaesthesia (100 mg of hyperbaric lidocaine 5% plus morphine 0.2 mg) were randomly allocated to one of two groups. Just after birth, alizapride-50 mg (alizapride group) or metoclopramide-10 mg (metoclopramide group) were injected i.v. Patients were assessed after surgery for pruritus (absent, mild, moderate or severe) or other untoward symptoms.

Results: In the metoclopramide group, pruritus was absent in 5 (12%) patients, mild in 23 (55%), moderate in 11 (26%), and severe in 3 (7%), while in the alizapride group, these incidences were, respectively, 5 (12%), 33 (79%), 4 (10%), and 0 (P=0.045, chi(2)-test). There was no difference in the incidence of side-effects, which were all minor.

Conclusions: Alizapride reduced the severity of morphine-induced pruritus.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Analgesics, Opioid / adverse effects*
  • Anesthesia, Obstetrical / adverse effects*
  • Anesthesia, Obstetrical / methods
  • Anesthesia, Spinal / adverse effects
  • Antiemetics / therapeutic use
  • Antipruritics / therapeutic use*
  • Cesarean Section
  • Double-Blind Method
  • Female
  • Humans
  • Morphine / adverse effects*
  • Pruritus / chemically induced
  • Pruritus / prevention & control*
  • Pyrrolidines / therapeutic use*
  • Severity of Illness Index

Substances

  • Analgesics, Opioid
  • Antiemetics
  • Antipruritics
  • Pyrrolidines
  • Morphine
  • alizapride